Showing 6551-6560 of 19355 results for "".
Strategies to Safeguard Brain Health in MS
https://reachmd.com/programs/neurofrontiers/strategies-to-safeguard-brain-health-in-ms/54774/Cognitive changes are a major concern for patients living with multiple sclerosis (MS), underscoring the importance of proactive brain health strategies. Join Dr. Christopher Lock as he explores practical approaches to preserving cognitive function and discusses the evolving therapeutic landscape aiRethinking Progression in Multiple Sclerosis
https://reachmd.com/programs/neurofrontiers/rethinking-progression-in-multiple-sclerosis/54235/Even with a growing arsenal of disease-modifying therapies, many patients with multiple sclerosis continue to accumulate disability independent of relapses. Axonal injury, incomplete remyelination, and compartmentalized inflammation within the central nervous system are now recognized as key driversRethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color
https://reachmd.com/programs/dermconsult/rethinking-quality-of-life-tools-for-psoriasis-patients-with-skin-of-color/39691/Psoriasis can have a disproportionate quality-of-life impact on patients with skin of color, but commonly used tools like the Dermatology Life Quality Index (DLQI) may not fully capture the social, emotional, and cultural burden unique to these patients. Join Dr. Megan Hauptman as she explores the lHow Can We Make Psoriasis Research More Equitable?
https://reachmd.com/programs/dermconsult/how-can-we-make-psoriasis-research-more-equitable/39692/Making psoriasis care more equitable is a key priority in dermatology today—and it requires research that intentionally centers patients with skin of color through diverse recruitment and culturally competent trial design. Join Dr. Megan Hauptman, Clinical Research Fellow in the Program for ClinicalWho’s Missing from Multiple Sclerosis Research?
https://reachmd.com/programs/neurofrontiers/diversity-equity-inclusion-multiple-sclerosis-research/54236/Multiple sclerosis (MS) research is evolving, but important gaps remain in how well studies reflect the diversity of people living with the disease. To address this gap, a recent study identified practical, consensus-driven priorities for advancing equity, diversity, and inclusion across MS researchCOLLAB CORNER - What’s Coming Down the Pipeline in Patient Care
https://reachmd.com/podcasts/collaborative-corner-the-podcast/whats-coming-down-the-pipeline-in-patient-care/54780/In this episode, Marc Bloomenstein, OD, FAAO, talks with Mitch Ibach, OD, FAAO, who practices at Vance Thompson Vision, in Sioux Falls, South Dakota, an OD-MD tertiary referral center. The pair opened the conversation with what’s new and exciting in patient care, including a newly-approved presbyopiCommitment to Clinical Evidence in Regenerative Aesthetics
https://reachmd.com/series/c-suite-chats/commitment-to-clinical-evidence-in-regenerative-aesthetics/54693/Laura Ellis, MD, CEO and Co-Founder of LevEllis, Inc., discusses the current state of aesthetic regenerative medicine and the importance of clinical evidence as the field continues to advance.Octane Aesthetics Tech Forum: Structural Adipose Tissue is Next Frontier
https://reachmd.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-structural-adipose-tissue-is-next-frontier/54707/At the 2026 Octane Aesthetics Tech Forum, Christopher Khorsandi, MD, board-certified plastic surgeon, and Chief Medical Officer of Tiger Aesthetics, joined the “Future of Aesthetics” panel to discuss what’s next for the field. In this video interview, he explains why structural adipose tissue couldConnections for the Future of Dermatology
https://reachmd.com/series/skin-minute/connections-for-the-future-of-dermatology/54688/Frederick Beddingfield, MD, PhD, recaps the Dermatology Summit 2026, a meeting to connect innovators and investors in the field of dermatology.Changing the Course of COPD: What’s New in Detection and Treatment
https://reachmd.com/programs/clinicians-roundtable/copd-detection-treatment-updates/54182/Significant advances in COPD management are redefining how clinicians detect and treat this chronic disease. Hear from Mr. Brian Bizik, a physician assistant and Respiratory Care Coordinator at Terry Reilly Health Centers in Idaho, as he shares key updates in COPD, including a new focus on disease a